%0 Journal Article
%T Successful engineering of a highly potent single-chain variable-fragment (scFv) bispecific antibody to target disialoganglioside (GD2) positive tumors
%A Brian H. Santich
%A Hong Xu
%A Mahiuddin Ahmed
%A Ming Cheng
%A Morgan Huse
%A Nai-Kong V. Cheung
%J Archive of "Oncoimmunology".
%D 2016
%R 10.1080/2162402X.2016.1168557
%K Affinity
%K bispecific
%K disialoganglioside GD2
%K immunotherapy
%K scFv
%K stability
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938304/